- Sarpogrelate
-
- $2785.00
-
2026-05-11
- CAS:125926-17-2
- Purity:
- Supply Ability: 10g
- Sarpogrelate USP/EP/BP
-
- $1.10
-
2025-11-18
- CAS:125926-17-2
- Min. Order: 1g
- Purity: 99.9%
- Supply Ability: 100 Tons min
|
| | Sarpogrelate Basic information |
| Product Name: | Sarpogrelate | | Synonyms: | (+/-)-2-(dimethylamino)-1-{(o-(m-methoxyphenethyl)phenoxy)methyl}ethyl hydrogen succinate;SARPOGRELATE;Butanedioic acid, mono[2-(dimethylamino)-1-[[2-[2-(3-methoxyphenyl)ethyl]phenoxy]methyl]ethyl] ester (9CI);4-[1-(dimethylamino)-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxobutanoic acid;4-[1-(dimethylamino)-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxo-butanoic acid;4-[1-(dimethylaminomethyl)-2-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]ethoxy]-4-keto-butyric acid;Sapogrelate;Butanedioic acid, 1-[2-(diMethylaMino)-1-[[2-[2-(3-Methoxyphenyl)ethyl]phenoxy]Methyl]ethyl] ester | | CAS: | 125926-17-2 | | MF: | C24H31NO6 | | MW: | 429.51 | | EINECS: | | | Product Categories: | | | Mol File: | 125926-17-2.mol |  |
| | Sarpogrelate Chemical Properties |
| Boiling point | 585.9±50.0 °C(Predicted) | | density | 1.164±0.06 g/cm3(Predicted) | | pka | 4.25±0.17(Predicted) |
| | Sarpogrelate Usage And Synthesis |
| Uses | Sarpogrelate (MCI-9042) is a new, specific orally active 5-HT2 receptor antagonist, Sarpogrelate increases platelet aggregation and has hemostasis effect, and can be used for the research of Buerger’s disease[1]. | | Definition | ChEBI: Sarpogrelate is a stilbenoid and a hemisuccinate. | | IC 50 | 5-HT2 Receptor | | References | [1] A Rydzewski, et al. The effect of a 5HT2 receptor antagonist sarpogrelate (MCI-9042) treatment on platelet function in Buerger's disease. Thromb Res. 1996 Dec 15;84(6):445-52. DOI:10.1016/s0049-3848(96)00212-5 |
| | Sarpogrelate Preparation Products And Raw materials |
|